The Pfizer-Astellas Alliance has launched this independent medical education funding opportunity to address rapidly changing treatment approaches for advanced and muscle invasive bladder cancer. Focus on independent medical education. Eligible applicants include medical, nursing, allied health, and pharmacy professional schools, healthcare institutions, professional organizations, medical societies, and qualifying medical education companies. The funding is specifically intended for independent medical education. ConclusionThe Astellas-Pfizer Independent Medical Education Grant provides an opportunity for eligible healthcare education organizations to address important knowledge gaps surrounding the rapidly changing treatment landscape for la/mUC and MIBC.